|
Introduction to Drug Development
and the
IND Process
- FDA Organization
- Overview of Drug Development
- Discovery and Development Milestones
- The IND Process
- Special Considerations for IND's
- Recent Changes
- Maintaining IND's
- Key Decisions in Drug Development
- FDA Interactions
- Accelerated Development Options
- Regulatory Intelligence
|
Meeting the Regulatory Requirements for
New Drug Applications (NDA's)
Day 1:
Meeting the Regulatory Requirements for NDA's
- FDA Organization
- Organization and Content of NDA's and BLA's
- FDA Review of NDA's and BLA's
- Recent Changes
- Regulatory Intelligence
Day 2:
Preparing for the NDA Submission
A real-time exercise during which the company begins to fill in the Table
of Contents of the NDA, assembles the documents available
thus far and starts to plan for the submission.
|
